Yi Tong

发表

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Lili Zhu, Qian Jiao, Rui Wang, 2018, Front. Pharmacol..

Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR

Tao Zhang, Xia Wang, Honglin Li, 2019 .

Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2

Honglin Li, Gengfu Xiao, Zhenjiang Zhao, 2020, bioRxiv.

Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors

Xia Wang, Yufang Xu, Shiliang Li, 2017, Front. Chem..

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Yong Wang, Honglin Li, Lili Zhu, 2020, Protein & Cell.

Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFRL858R/T790M/C797S.

Xia Wang, Honglin Li, Zhenjiang Zhao, 2019, ACS medicinal chemistry letters.

Discovery and Structural Optimization of N5-Substituted 6,7-Dioxo-6,7-dihydropteridines as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.

Xia Wang, Honglin Li, Zhenjiang Zhao, 2016, Journal of medicinal chemistry.

Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents

Honglin Li, Zhenjiang Zhao, Yufang Xu, 2016 .

Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.

Honglin Li, Jiankun Lyu, Zhenjiang Zhao, 2018, Journal of medicinal chemistry.